|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
BR9608278A
(pt)
|
1995-04-11 |
1999-10-13 |
Merck & Co Inc |
Processo para produzir um intermediário de dipeptìdeo de um composto à base de dipeptìdeo
|
|
WO1999002546A1
(en)
|
1997-07-08 |
1999-01-21 |
Human Genome Sciences, Inc. |
123 human secreted proteins
|
|
AU751784B2
(en)
|
1997-08-29 |
2002-08-29 |
Innogenetics N.V. |
Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
|
|
US6413783B1
(en)
|
1997-09-18 |
2002-07-02 |
Meso Scale Technologies, Llc |
Assay sonication apparatus and methodology
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
CA2407352A1
(en)
|
2000-04-21 |
2001-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of acne vulgaris
|
|
US6846650B2
(en)
|
2000-10-25 |
2005-01-25 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
|
US6855517B2
(en)
|
2000-11-20 |
2005-02-15 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
US7528227B2
(en)
|
2004-03-23 |
2009-05-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Histone H2A peptide derivatives and uses thereof
|
|
US7163943B2
(en)
*
|
2001-09-21 |
2007-01-16 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
AU2005222776A1
(en)
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
|
WO2005099741A1
(ja)
|
2004-04-08 |
2005-10-27 |
Noevir Co., Ltd. |
運動ニューロン疾患治療薬
|
|
US20060068434A1
(en)
|
2004-09-21 |
2006-03-30 |
Jay Stoerker |
Methods and compositions for detecting cancer using components of the U2 spliceosomal particle
|
|
EP1844148A2
(en)
|
2005-01-31 |
2007-10-17 |
University of Iowa Research Foundation |
Nucleic acid silencing of huntington's disease gene
|
|
US20090074721A1
(en)
|
2005-06-06 |
2009-03-19 |
Vgx Pharmaceuticals, Inc. |
Methods for treating viral infection with oral or injectibel drug solution
|
|
US20080248099A1
(en)
|
2005-11-11 |
2008-10-09 |
Ishii Douglas N |
Method for Treating Disease or Disorder of Adult Central Nervous System Associated with Tissue Shrinkage or Atrophy by Administration of Insulin
|
|
ES2453374T3
(es)
|
2006-09-20 |
2014-04-07 |
The Queen's University Of Belfast |
Método para determinar si una célula tumoral presenta potencial invasivo y/o metastásico, y agentes moduladores de la transformación maligna
|
|
WO2008097861A2
(en)
|
2007-02-02 |
2008-08-14 |
Braincells, Inc. |
MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS
|
|
US20090143418A1
(en)
|
2007-11-30 |
2009-06-04 |
The Regents Of The University Of Michigan |
Compositions and Methods for Preventing and Treating Hair Growth Cycle-Related Conditions
|
|
GB0809821D0
(en)
|
2008-05-30 |
2008-07-09 |
Univ Aberdeen |
Treatment and diagnosis of behavioural disorders
|
|
TW201034684A
(en)
|
2009-02-18 |
2010-10-01 |
Genentech Inc |
Method for inhibiting neurodegeneration
|
|
CA2757354A1
(en)
|
2009-04-02 |
2010-10-07 |
Laura P.W. Ranum |
Nucleotide repeat expansion-associated polypeptides and uses thereof
|
|
EP3569254B1
(en)
|
2009-04-17 |
2022-07-20 |
Oxford University Innovation Limited |
Composition for delivery of genetic material
|
|
WO2010132982A1
(en)
|
2009-05-18 |
2010-11-25 |
Ottawa Hospital Research Institute |
Treatment of muscle disease characterized by insulin resistance
|
|
WO2011028912A2
(en)
|
2009-09-03 |
2011-03-10 |
University Of Tennessee Research Foundation |
A biomarker for neurodegeneration in neurological disease
|
|
US20130085169A1
(en)
|
2010-04-02 |
2013-04-04 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
|
|
EP2751284B1
(en)
|
2011-08-31 |
2017-01-11 |
The University Of Manchester |
Method for diagnosing a neurodegenerative disease.
|
|
CN108285491B
(zh)
|
2012-02-29 |
2021-08-10 |
桑格摩生物科学股份有限公司 |
治疗亨廷顿氏病的方法和组合物
|
|
KR101417272B1
(ko)
|
2012-05-15 |
2014-07-14 |
경상대학교산학협력단 |
메트포민 및/또는 타이모퀴논을 포함하는 임신중 알코올 노출에 의한 신경질환 치료 또는 예방용 약학적 조성물
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
PT2948777T
(pt)
|
2013-01-22 |
2019-09-26 |
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V |
Proteínas de repetição por dipeptídeos como alvo terapêutico em doenças neurodegenerativas com expansão de hexanucleotídico repetido
|
|
WO2014114303A1
(en)
|
2013-01-22 |
2014-07-31 |
Deutsches Zentrum Für Neurodegenerative Erkrankungen |
Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
|
|
EP2948471A4
(en)
|
2013-01-24 |
2016-08-10 |
Mayo Foundation |
METHOD AND MATERIALS FOR DETECTING POSITIVE FRONTOTEMPORAL PAPER DEGENERATION BY C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION OR AMYOTROPHATE LATERAL SCLEROSIS BY C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION
|
|
WO2014159247A1
(en)
|
2013-03-14 |
2014-10-02 |
University Of Florida Research Foundation, Inc. |
Di-amino acid repeat-containing proteins associated with als
|
|
CA2904794C
(en)
|
2013-03-15 |
2021-11-23 |
Peter Walter |
Modulators of the eif2alpha pathway
|
|
WO2014186746A1
(en)
|
2013-05-16 |
2014-11-20 |
University Of Florida Research Foundation, Inc. |
HAIRPIN mRNA ELEMENTS AND METHODS FOR THE REGULATION OF PROTEIN TRANSLATION
|
|
EP2837390A1
(en)
*
|
2013-08-15 |
2015-02-18 |
Universitäts-Kinderspital beider Basel |
Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders
|
|
WO2016025692A1
(en)
|
2014-08-13 |
2016-02-18 |
The Scripps Research Institute |
Treatment of c9ftd/als by targeting rna expanded repeat sequences
|
|
WO2016191241A1
(en)
|
2015-05-27 |
2016-12-01 |
Mmc & Company Llc |
Dual target mitochondrial impinging pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
|
|
US10509045B2
(en)
|
2015-05-29 |
2019-12-17 |
University Of Florida Research Foundation, Incorporated |
Methods for diagnosing Huntington's disease
|
|
US10940161B2
(en)
|
2016-04-04 |
2021-03-09 |
University Of Florida Research Foundation, Incorporated |
Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
|
|
JP2019524834A
(ja)
*
|
2016-08-18 |
2019-09-05 |
オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
ビグアナイド系による発達障害の治療方法
|
|
WO2018195110A1
(en)
*
|
2017-04-17 |
2018-10-25 |
University Of Florida Research Foundation, Incorporated |
Regolation of ran translation by pkr and eif2a-p pathways
|
|
JP2020535448A
(ja)
|
2017-09-25 |
2020-12-03 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． |
Ｒａｎタンパク質の検出のための免役アッセイ
|
|
US11903910B2
(en)
|
2017-09-26 |
2024-02-20 |
University Of Florida Research Foundation, Incorporated |
Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders
|
|
US20220267776A1
(en)
|
2019-07-05 |
2022-08-25 |
University Of Florida Research Foundation, Incorporated |
Methods for treating ran protein-associated neurological diseases
|
|
WO2021055880A1
(en)
|
2019-09-20 |
2021-03-25 |
University Of Florida Researchfoundation, Incorporated |
Detection of antibodies against ran proteins from serum and tissue lysates
|